Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats

Nutrition & Metabolism - 2011
Ji Young Jung1, Yeni Lim1, Min Sun Moon1, Ji Yeon Kim1, Oran Kwon1
1Department of Nutritional Science and Food Management, Ewha Womans University, 11-1 Daehyeon-dong, Seodeamun-gu, Seoul, 120-750, Republic of Korea

Tóm tắt

AbstractBackgroundQuercetin derivatives in onions have been regarded as the most important flavonoids to improve diabetic status in cells and animal models. The present study was aimed to examine the hypoglycemic and insulin-sensitizing capacity of onion peel extract (OPE) containing high quercetin in high fat diet/streptozotocin-induced diabetic rats and to elucidate the mechanism of its insulin-sensitizing effect.MethodsMale Sprague-Dawley rats were fed the AIN-93G diet modified to contain 41.2% fat and intraperitoneally injected with a single dose of streptozotocin (40 mg/kg body weight). One week after injection, the rats with fasting blood glucose levels above 126 mg/dL were randomly divided into 4 groups to treat with high fat diet containing 0 (diabetic control), 0.5, or 1% of OPE or 0.1% quercetin (quercetin equivalent to 1% of OPE) for 8 weeks. To investigate the mechanism for the effects of OPE, we examined biochemical parameters (insulin sensitivity and oxidative stresses) and protein and gene expressions (pro-inflammatory cytokines and receptors).ResultsCompared to the diabetic control, hypoglycemic and insulin-sensitizing capability of 1% OPE were demonstrated by significant improvement of glucose tolerance as expressed in incremental area under the curve (P= 0.0148). The insulin-sensitizing effect of OPE was further supported by increased glycogen levels in liver and skeletal muscle (P< 0.0001 andP= 0.0089, respectively). Quantitative RT-PCR analysis showed increased expression of insulin receptor (P= 0.0408) and GLUT4 (P= 0.0346) in muscle tissues. The oxidative stress, as assessed by superoxide dismutase activity and malondialdehyde formation, plasma free fatty acids, and hepatic protein expressions of IL-6 were significantly reduced by 1% OPE administration (P= 0.0393, 0.0237, 0.0148 and 0.0025, respectively).ConclusionOPE might improve glucose response and insulin resistance associated with type 2 diabetes by alleviating metabolic dysregulation of free fatty acids, suppressing oxidative stress, up-regulating glucose uptake at peripheral tissues, and/or down-regulating inflammatory gene expression in liver. Moreover, in most cases, OPE showed greater potency than pure quercetin equivalent. These findings provide a basis for the use of onion peel to improve insulin insensitivity in type 2 diabetes.

Từ khóa


Tài liệu tham khảo

Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.

Panda S, Kar A: Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside. Biofactors. 2007, 31: 201-210. 10.1002/biof.5520310307.

Aslan M, Deliorman Orhan D, Orhan N, Sezik E, Yesilada E: In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. J Ethnopharmacol. 2007, 109: 54-59. 10.1016/j.jep.2006.07.001.

Cunha WR, Arantes GM, Ferreira DS, Lucarini R, Silva ML, Furtado NA, da Silva Filho AA, Crotti AE, Araujo AR: Hypoglicemic Effect of Leandra lacunosa in normal and alloxan-induced diabetic rats. Fitoterapia. 2008, 79: 356-360. 10.1016/j.fitote.2008.04.002.

Babu PS, Srinivasan K: Influence of dietary capsaicin and onion on the metabolic abnormalities associated with streptozotocin induced diabetes mellitus. Mol Cell Biochem. 1997, 175: 49-57. 10.1023/A:1006881027166.

Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005, 365: 1333-1346. 10.1016/S0140-6736(05)61032-X.

Kook S, Kim GH, Choi K: The antidiabetic effect of onion and garlic in experimental diabetic rats: meta-analysis. J Med Food. 2009, 12: 552-560. 10.1089/jmf.2008.1071.

Shetty A, Rashmi R, Rajan M, Sambaiah K, Salimath P: Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats. Nutr Res. 2004, 24: 373-381. 10.1016/j.nutres.2003.11.010.

Matsui T, Ogunwande LA, Abesundara KJM, Matsumoto K: Antihyperglycemic potential of natural products. Mini-Rev Med Chem. 2006, 6: 109-120. 10.2174/138955706776073484.

Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J: Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr. 2005, 135: 2299-2304.

Mahesh T, Menon VP: Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res. 2004, 18: 123-127. 10.1002/ptr.1374.

Coskun O, Kanter M, Korkmaz A, Oter S: Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res. 2005, 51: 117-123. 10.1016/j.phrs.2004.06.002.

Kobori M, Masumoto S, Akimoto Y, Takahashi Y: Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res. 2009, 53: 859-868. 10.1002/mnfr.200800310.

Slimestad R, Fossen T, Vagen IM: Onions: a source of unique dietary flavonoids. J Agric Food Chem. 2007, 55: 10067-10080. 10.1021/jf0712503.

Smith C, Lombard KA, Peffley EB, Liu W: Genetic analysis of quercetin in onion (Allium cepa L.) 'Lady Raider'. Texas J Agric Nat Resource. 2003, 16: 24-28.

Park J, Kim J, Kim MK: Onion flesh and onion peel enhance antioxidant status in aged rats. J Nutr Sci Vitaminol (Tokyo). 2007, 53: 21-29. 10.3177/jnsv.53.21.

Nemeth K, Piskula MK: Food content, processing, absorption and metabolism of onion flavonoids. Crit Rev Food Sci Nutr. 2007, 47: 397-409. 10.1080/10408390600846291.

Kanter M, Altan MF, Donmez S, Ocakci A, Kartal ME: The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct. 2007, 25: 747-752. 10.1002/cbf.1397.

Singleton VL, Rossi JA: Colorimetry of total phenolics with phosphomolybdic phosphorungstic acid reagents. Am J Enol Vitic. 1965, 16: 44-158.

Hertog MGL, Hollman PCH, Venema DP: Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits. J Agric Food Chem. 1992, 40: 1591-1598.

Wolever TM, Jenkins DJ, Jenkins AL, Josse RG: The glycemic index: methodology and clinical implications. Am J Clin Nutr. 1991, 54: 846-854.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.

Hanley AJG, Stern MP, Williams K, Haffner SM: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease. Diabetes Care. 2002, 25: 1177-1184. 10.2337/diacare.25.7.1177.

Lo S, Russell JC, Taylor AW: Determination of glycogen in small tissue samples. J Appl Physiol. 1970, 28: 234-236.

Rerup CC: Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev. 1970, 22: 485-518.

Parveen K, Khan MR, Mujeeb M, Siddiqui WA: Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in liver of type 2 diabetic rats. Chem Biol Interact. 2010, 186: 219-227. 10.1016/j.cbi.2010.04.023.

Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P: Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005, 52: 313-320. 10.1016/j.phrs.2005.05.004.

Islam MS, Choi H, Loots du T: Effects of dietary onion (Allium Cepa L.) in a high-fat diet streptozotocin-induced diabetes rodent model. Ann Nutr Metab. 2008, 53: 6-12. 10.1159/000152868.

Luo J, Quan J, Tsai J, Hobensack CK, Sullivan C, Hector R, Reaven GM: Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism. 1998, 47: 663-668. 10.1016/S0026-0495(98)90027-0.

Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM: A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 2000, 49: 1390-1394. 10.1053/meta.2000.17721.

Baron AD, Brechtel G, Wallace P, Edelman SV: Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988, 255: E769-E774.

Zhang F, Ye C, Li G, Ding W, Zhou W, Zhu H, Chen G, Luo T, Guang M, Liu Y, Zhang D, Zheng S, Yang J, Gu Y, Xie X, Luo M: The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp Anim. 2003, 52: 401-407. 10.1538/expanim.52.401.

Kwon O, Eck P, Chen S, Corpe CP, Lee JH, Kruhlak M, Levine M: Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 2007, 21: 366-377. 10.1096/fj.06-6620com.

Defronzo RA, Tripathy D: Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009, 32: S157-S163. 10.2337/dc09-S302.

Bilan PJ, Samokhvalov V, Koshkina A, Schertzer JD, Samaan MC, Klip A: Direct and machrophage-mediated actions of fatty acids causing insulin resistance in muscle cells. Arch Physiol Biochem. 2009, 115: 176-190. 10.1080/13813450903079314.

Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867. 10.1038/nature05485.

Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A, Liu-Bryan R, Glass CK, Neels JG, Olefsky JM: A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem. 2007, 282: 35279-35292. 10.1074/jbc.M706762200.

Pickup JC, Crook MA: Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia. 1998, 41: 1241-1248. 10.1007/s001250051058.

Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA: Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm. 2010, 2010: 1-11. 10.1155/2010/453892.

Thông tin
Thông tin xuất bản

Nutrition & Metabolism

Thông tin tác giả